Stephen L Silvestro Optimize Rx Corp (OPRX) insider trading activity

Stephen L Silvestro is Chief Commercial Officer of OptimizeRx Corp. Currently has a direct ownership of 80,848 shares of OPRX, which is worth approximately $396,963. The most recent transaction as insider was on Dec 19, 2024, when has been sold 2,576 shares (Common Stock) at a price of $4.75 per share, resulting in proceeds of $12,236. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80.8K

10.98% 3M change

1621.27% 12M change

Total Value Held $396,963

Stephen L Silvestro Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2024	SELL Payment of exercise price or tax liability	$12,236 $4.75 p/Share	2,576 Reduced 3.09%	80,848 Common Stock
Dec 19 2024	BUY Exercise of conversion of derivative security	-	6,546 Added 7.28%	83,424 Common Stock
Oct 03 2024	SELL Payment of exercise price or tax liability	$20,491 $7.83 p/Share	2,617 Reduced 3.29%	76,878 Common Stock
Oct 03 2024	BUY Exercise of conversion of derivative security	-	6,649 Added 7.72%	79,495 Common Stock
May 02 2024	SELL Payment of exercise price or tax liability	$378,940 $10.7 p/Share	35,415 Reduced 32.71%	72,846 Common Stock
May 02 2024	BUY Exercise of conversion of derivative security	-	90,000 Added 45.39%	108,261 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	7,750 Added 36.12%	13,706 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$10,654 $15.95 p/Share	668 Reduced 10.08%	5,956 Common Stock
Mar 01 2024	BUY Exercise of conversion of derivative security	-	1,927 Added 22.54%	6,624 Common Stock
Oct 03 2023	SELL Payment of exercise price or tax liability	$13,781 $7.06 p/Share	1,952 Reduced 29.36%	4,697 Common Stock
Oct 03 2023	BUY Exercise of conversion of derivative security	-	6,649 Added 50.0%	6,649 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$12,097 $18.11 p/Share	668 Reduced 13.03%	4,459 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	-	1,927 Added 27.32%	5,127 Common Stock
Aug 16 2022	BUY Open market or private purchase	$50,112 $15.66 p/Share	3,200 Added 50.0%	3,200 Common Stock
Dec 17 2021	SELL Open market or private sale	$726,534 $54.87 p/Share	13,241 Reduced 100.0%	0 Common Stock Pursuant ...
Dec 17 2021	BUY Exercise of conversion of derivative security	$99,440 $7.51 p/Share	13,241 Added 50.0%	13,241 Common Stock
Nov 17 2021	SELL Open market or private sale	$979,569 $73.98 p/Share	13,241 Reduced 100.0%	0 Common Stock Pursuant ...
Nov 17 2021	BUY Exercise of conversion of derivative security	$99,440 $7.51 p/Share	13,241 Added 50.0%	13,241 Common Stock
Oct 18 2021	SELL Open market or private sale	$1,130,517 $85.38 p/Share	13,241 Reduced 100.0%	0 Common Stock Pursuant ...
Oct 18 2021	BUY Exercise of conversion of derivative security	$99,440 $7.51 p/Share	13,241 Added 50.0%	13,241 Common Stock
Sep 17 2021	SELL Open market or private sale	$924,159 $69.79 p/Share	13,242 Reduced 100.0%	0 Common Stock Pursuant ...
Sep 17 2021	BUY Exercise of conversion of derivative security	$99,447 $7.51 p/Share	13,242 Added 50.0%	13,242 Common Stock
Aug 17 2021	SELL Open market or private sale	$773,465 $58.41 p/Share	13,242 Reduced 100.0%	0 Common Stock Pursuant ...
Aug 17 2021	BUY Exercise of conversion of derivative security	$99,447 $7.51 p/Share	13,242 Added 50.0%	13,242 Common Stock
Jul 20 2021	SELL Open market or private sale	$666,602 $50.34 p/Share	13,242 Reduced 100.0%	0 Common Stock Pursuant ...

SLS

Stephen L Silvestro

Chief Commercial Officer

Rochester, MI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX

Account